A new human cancer cell proliferation inhibition sesquiterpene, dryofraterpene a, from medicinal plant dryopteris fragrans (L.) schott

16Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The global burden of cancer continues to increase largely with the aging and growth of the world population. The purpose of the present work was to find new anticancer molecules from a natural source. We utilized chromatographic methods to isolate compounds from medicinal plant Dryopteris fragrans (L.) Schott. The structure of the new compounds was determined by spectroscopic and spectrometric data (1D NMR, 2D NMR, and EMI-MS). Their anti-proliferation effects against five human cancer cell lines including A549, MCF7, HepG2, HeLa, and PC-3 were evaluated by CCK-8 andlactate dehydrogenase (LDH) assay. A new sesquiterpene, (7S, 10S)-2,3-dihydroxy-calamenene-15-carboxylic acid methyl ester (1), and two known compounds (2 and 3) were isolated. The new sesquiterpene was named dryofraterpene A and significantly inhibited cancer cell proliferation without any obvious necrosis below a 10 μM concentration. In conclusion, a novel anticancer sesquiterpene together with two known compounds was isolated, which might be a promising lead compound for the treatment of cancer.

Cite

CITATION STYLE

APA

Zhong, Z. C., Zhao, D. D., Liu, Z. D., Jiang, S., & Zhang, Y. L. (2017). A new human cancer cell proliferation inhibition sesquiterpene, dryofraterpene a, from medicinal plant dryopteris fragrans (L.) schott. Molecules, 22(1). https://doi.org/10.3390/molecules22010180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free